Pages that link to "Q38967799"

The following pages link to Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification (Q38967799):

Displaying 11 items.

• Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes. (Q36306094) (← links)
• Mitochondrial Complex II: At the Crossroads (Q39129680) (← links)
• Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays (Q45066002) (← links)
• SEOM clinical guideline for treatment of kidney cancer (2017). (Q48310227) (← links)
• Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. (Q55618938) (← links)
• VSTM2A Overexpression is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney (Q57033240) (← links)
• Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma (Q64264992) (← links)
• The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort (Q90439549) (← links)
• Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression (Q90710823) (← links)
• Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice (Q92372097) (← links)
• Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial (Q99717731) (← links)